{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:32:24Z","timestamp":1791995544448,"version":"4.4.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bonr.2025.101890","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T08:02:21Z","timestamp":1764144141000},"page":"101890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Predictors of clinically meaningful bone mineral density gains with romosozumab: An explainable machine leaning analysis of a real-world cohort"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7315-6274","authenticated-orcid":false,"given":"David Castro","family":"Corredor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-5542","authenticated-orcid":false,"given":"Luis \u00c1ngel Calvo","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2025.101890_bb0005","article-title":"Machine learning\u2013based prediction of osteoporosis and fracture risk using clinical and biochemical data","volume":"143","author":"Chen","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bonr.2025.101890_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1152\/physrev.2001.81.1.419","article-title":"Sex steroids and bone","volume":"81","author":"Compston","year":"2001","journal-title":"Physiol. Rev."},{"issue":"16","key":"10.1016\/j.bonr.2025.101890_bb0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.bonr.2025.101890_bb0020","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/jbmr.3427","article-title":"FRAME study: the foundation effect of building bone with 1 year of romosozumab therapy \u2014 post hoc analyses of baseline BMD and responses","volume":"33","author":"Cosman","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bonr.2025.101890_bb0025","first-page":"299","article-title":"The role of parathyroid hormone in bone turnover and osteoporosis therapy","volume":"13","author":"Drake","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.bonr.2025.101890_bb0030","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00198-024-07155-9","article-title":"The effect of romosozumab on bone mineral density depending on prior treatment: a prospective, multicentre cohort study in Switzerland","volume":"35","author":"Everts-Graber","year":"2024","journal-title":"Osteoporos. Int."},{"issue":"5","key":"10.1016\/j.bonr.2025.101890_bb0035","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/mr\/roae008","article-title":"Association between P1NP value and increases in bone mineral density in patients treated with romosozumab","volume":"34","author":"Hattori","year":"2024","journal-title":"Mod. Rheumatol."},{"issue":"1","key":"10.1016\/j.bonr.2025.101890_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40520-018-1109-4","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"31","author":"Kanis","year":"2019","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.bonr.2025.101890_bb0045","article-title":"Explainable machine learning models for predicting response to anti-osteoporotic therapy in postmenopausal women","volume":"14","author":"Li","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bonr.2025.101890_bb0050","series-title":"Advances in Neural Information Processing Systems","first-page":"4765","article-title":"A unified approach to interpreting model predictions","volume":"30","author":"Lundberg","year":"2017"},{"key":"10.1016\/j.bonr.2025.101890_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2024.117164","article-title":"Real-world effects, safety, and predictors of romosozumab in primary and secondary osteoporosis","volume":"186","author":"Mineta","year":"2024","journal-title":"Bone"},{"issue":"9","key":"10.1016\/j.bonr.2025.101890_bb0060","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.3390\/jcm14092958","article-title":"Real-world evaluation of 12-month romosozumab treatment in Korean women with severe osteoporosis: potential synergy with hormone therapy","volume":"14","author":"Park","year":"2025","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.bonr.2025.101890_bb0065","first-page":"2832","article-title":"Determinants of rate of bone loss in normal postmenopausal women","volume":"80","author":"Reid","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bonr.2025.101890_bb0070","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr. Rev."},{"issue":"15","key":"10.1016\/j.bonr.2025.101890_bb0075","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bonr.2025.101890_bb0080","first-page":"382","article-title":"Predictors of bone mass in perimenopausal women: a longitudinal study","volume":"143","author":"Slemenda","year":"1996","journal-title":"Am. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.bonr.2025.101890_bb0085","first-page":"3562","article-title":"Changes in bone density and bone turnover in late premenopausal and early postmenopausal women: effects of age and estradiol levels","volume":"88","author":"Sowers","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bonr.2025.101890_bb0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.bonr.2025.101890_bb0095","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J. R. Stat. Soc. Ser. B"}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187225000671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:42:35Z","timestamp":1766166155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187225000671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":19,"alternative-id":["S2352187225000671"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101890","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of clinically meaningful bone mineral density gains with romosozumab: An explainable machine leaning analysis of a real-world cohort","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2025.101890","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101890"}}